Mangoceuticals, Inc. MGRX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 75.76% | 29.68% | -42.15% | -281.06% | -126.51% |
| Total Depreciation and Amortization | -64.75% | -29.73% | -37.92% | 185.52% | 2,472.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -96.70% | -15.57% | -86.91% | 1,014.67% | 269.52% |
| Change in Net Operating Assets | 702.96% | -25.81% | 2,076.16% | -5,090.32% | 125.41% |
| Cash from Operations | 79.27% | 42.36% | 4.59% | -6.48% | 20.34% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -92.52% | -- | 300.00% | -- | 500.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -84.28% | -- | 191.45% | -- | 345.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -100.00% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -75.26% | -- | 85.61% | 116.21% | -35.58% |
| Foreign Exchange rate Adjustments | -1,250.00% | -105.26% | 91.46% | 100.00% | 118.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 120.82% | -7,469.66% | 6,669.28% | 191.35% | -94.84% |